CNP
49
-6
AMAT
52
3
CA
30
3
BMY
76
2
D
41
-4
AVB
34
-3
A
43
-5
ACN
56
2
CCI
36
2
AIG
77
2
BF.B
48
-2
CSCO
64
6
ADT
50
2
BEN
55
2
AME
72
6
BWA
53
-7
CAG
41
-5
AVY
47
-7
AON
62
-5
ALL
56
2
CNP
49
-6
AMAT
52
3
CA
30
3
BMY
76
2
D
41
-4
AVB
34
-3
A
43
-5
ACN
56
2
CCI
36
2
AIG
77
2
BF.B
48
-2
CSCO
64
6
ADT
50
2
BEN
55
2
AME
72
6
BWA
53
-7
CAG
41
-5
AVY
47
-7
AON
62
-5
ALL
56
2
Financhill
Back

Innovent Biologics, Inc. Stock Predictions

14K Investors Got In Earlier. You Still Can.

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
47

IVBXF
Innovent Biologics, Inc.

Last Price:
$10.84
Seasonality Move:
5.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Valuation Up 5,000%. Shares Now $0.85 - Still Early?

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Innovent Biologics, Inc. Stock Forecast

  • Over the next 52 weeks, Innovent Biologics, Inc. has on average historically risen by 45.1% based on the past 6 years of stock performance.
  • Innovent Biologics, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Innovent Biologics, Inc. Stock Undervalued?
    The current Innovent Biologics, Inc. [IVBXF] share price is $10.84. The Score for IVBXF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • IVBXF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Innovent Biologics, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Innovent Biologics, Inc. has on average historically risen by 45.1% based on the past 6 years of stock performance.

Innovent Biologics, Inc. Stock Rating

Sell
47
Innovent Biologics, Inc. (IVBXF) is a Sell

Is Innovent Biologics, Inc. overpriced?

  • Innovent Biologics, Inc. has risen higher in 4 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Innovent Biologics, Inc. Stock Price History

Is IVBXF stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IVBXF is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
OTCM
Country:
China
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
innoventbio.com

52-Week Data

52-Week High:
15.12
52-Week Low:
3.91

Prediction Charts

Market Cap:
18.5B
Price in USD:
10.84
Volume:
25K
Beta:
0.04

Technical Analysis

SMA50:
11.35
SMA100:
11.93
SMA200:
9.89
52-Wk Change:
125.83%

Stock Predictions

  • Is Innovent Biologics, Inc. stock public?
    Yes, Innovent Biologics, Inc. is a publicly traded company.
  • What is the Innovent Biologics, Inc. stock quote today?
    The Innovent Biologics, Inc. stock price is 10.84 USD today.
  • How to buy Innovent Biologics, Inc. stock online?
    You can buy Innovent Biologics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-2 12.12 12.64 12.64 12.12
Dec-3 12.19 12.26 12.75 12.19
Dec-4 12.26 12.26 12.26 12.26
Dec-5 11.89 11.79 11.89 11.79
Dec-8 11.50 11.16 11.50 11.16
Dec-9 11.34 11.34 11.34 11.34
Dec-10 11.00 11.00 11.00 11.00
Dec-11 10.73 10.73 10.73 10.73
Dec-12 10.73 10.73 10.73 10.73
Dec-15 10.56 10.55 10.56 10.55
Dec-16 10.55 10.55 10.55 10.55
Dec-17 10.55 10.55 10.55 10.55
Dec-18 10.68 10.84 10.84 10.68
Dec-19 10.84 10.84 10.84 10.84

Innovent Biologics, Inc. Earnings

Data Unavailable

Innovent Biologics, Inc. Forecast Revenue Growth

Data Unavailable

* Innovent Biologics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.